Axon Enterprise Inc. (AXON): Price and Financial Metrics
AXON Price/Volume Stats
| Current price | $609.82 | 52-week high | $624.84 |
| Prev. close | $610.20 | 52-week low | $224.28 |
| Day low | $598.95 | Volume | 572,500 |
| Day high | $613.25 | Avg. volume | 553,776 |
| 50-day MA | $453.48 | Dividend yield | N/A |
| 200-day MA | $345.59 | Market Cap | 46.50B |
AXON Stock Price Chart Interactive Chart >
Axon Enterprise Inc. (AXON) Company Bio
Axovant Sciences is a clinical-stage biopharmaceutical company focused on the acquisition, development and commercialization of novel therapeutics for the treatment of dementia, a condition characterized by significant decline in mental capacity and impaired daily function. The company was founded in 2014 and is based in Hamilton, Bermuda.
AXON Price Returns
| 1-mo | 35.63% |
| 3-mo | 64.50% |
| 6-mo | 113.50% |
| 1-year | 168.80% |
| 3-year | 236.95% |
| 5-year | N/A |
| YTD | 136.06% |
| 2023 | 55.69% |
| 2022 | 5.69% |
| 2021 | 28.13% |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...